GlassScriptPhysician profile
Marissa Mobilia
NPI 1316620693
$1,008.11
in general payments reported to CMS, 2019-2025
19 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $195 · 2024: $437 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $165.27 | 2024-2025 | Vyepti |
| Biogen, INC. | $134.70 | 2023-2025 | Vumerity |
| Amneal Pharmaceuticals LLC | $123.39 | 2023-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Abbvie INC. | $101.57 | 2024-2025 | |
| Ucb, INC. | $77.95 | 2023-2024 | Rystiggo |
| Emd Serono, INC. | $50.70 | 2023-2024 | Mavenclad |
| Argenx US, INC. | $48.73 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $44.02 | 2024 | Ultomiris |
| Medtronic, INC. | $42.77 | 2025 | Percept PC Brainsense |
| Lilly USA, LLC | $36.23 | 2024 | Kisunla |
| Grifols USA, LLC | $31.63 | 2025 | Gamunex-C |
| Eisai INC. | $24.21 | 2025 | |
| Axsome Therapeutics, INC. | $22.24 | 2025 | Symbravo |
| Tris Pharma INC | $21.86 | 2023 | Dyanavel Xr |
| Ipsen Biopharmaceuticals, INC | $19.24 | 2025 | Dysport |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $17.67 | 2023 | |
| Catalyst Pharmaceuticals, INC. | $16.23 | 2023 | Fycompa |
| Otsuka America Pharmaceutical, INC. | $15.14 | 2023 | Nuedexta |
| Neos Therapeutics, LP | $14.56 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Mobilia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.